Chronic Nicotinamide riboside Chloride (p.o.; 400 mg/kg/day; for 16 weeks) supplementation increases plasma and intracellular NAD
+
content in a tissue-specific manner.
Animal Model:
10-week-old C57Bl/6J mice
Dosage:
400 mg/kg
Administration:
PO; daily; for 16 weeks
Result:
Increased plasma and intracellular NAD
+
content in a tissue-specific manner.
体外研究
Nicotinamide riboside Chloride (0.5 nM; 24 hours) reduces the acetylation status of Ndufa9 and SOD2.
Nicotinamide riboside Chloride increases intracellular and mitochondrial NAD
+
content in C2C12, Hepa1.6, and HEK293 cells in a concentration-dependent manner at concentrations ranging from 1-1000 μM.
Nicotinamide riboside chloride boosts NAD to restore antiviral poly(ADP-ribose) polymerase (PARP) functions to support innate immunity for coronavirus (CoVs), a cause of COVID-19.
Western Blot Analysis
Cell Line:
HEK293T cells
Concentration:
0.5 nM
Incubation Time:
24 hours
Result:
Reduced the acetylation status of Ndufa9 and SOD2.